Answer
Ivabradine is contraindicated in patients with severe hepatic insufficiency because it has not been studied in this population and a large increase in systemic exposure is anticipated.
Sources for this answer
- ProcoralanServier Laboratories Limited · emc · SmPC §4.2 Posology and method of administration · Version 22Document updated
Sources checked